Applied BioCode Corporation (TPE:6598)
Taiwan
· Delayed Price · Currency is TWD 19.40
+0.20 (1.04%)
May 9, 2025, 1:30 PM CST
Applied BioCode Revenue
In the year 2024, Applied BioCode had annual revenue of 343.07M TWD, down -13.18%. Applied BioCode had revenue of 84.98M in the quarter ending December 31, 2024, a decrease of -33.73%.
Revenue
343.07M
Revenue Growth
-13.18%
P/S Ratio
5.81
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.99B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.69B |
| Lumosa Therapeutics | 43.59M |